Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Michael V. Tatley"'
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
A case series of hepatotoxicity associated with an extract of Artemisia annua L. was identified through the New Zealand spontaneous adverse drug reaction reporting system. A. annua extract, produced using a supercritical carbon dioxide extraction met
Externí odkaz:
https://doaj.org/article/95dab8719c364a6295dda88e90d23ae2
Publikováno v:
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 1 (2021)
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 1 (2021)
Introduction Beta-blockers are key in the management of cardiovascular diseases but blocking airway β2-receptors can cause severe and sometimes fatal bronchoconstriction in people with asthma. Although cardioselective β1-blockers may be safer than
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 59(6)
Synthetic Cannabinoid Receptor Agonists (SCRA) were legally available in New Zealand (NZ) prior to May 2014. During the period November 2012-November 2019, reports of adverse events associated with SCRA use from across the country were submitted to t
Publikováno v:
Airway pharmacology and treatment.
Publikováno v:
Seminars in Thrombosis and Hemostasis. 43:806-808
Autor:
Michael V. Tatley, Ruth L. Savage
Publikováno v:
Drug Safety
Introduction We undertook an analysis of all the reports to the New Zealand Centre for Adverse Reactions Monitoring of a roxithromycin/warfarin interaction after two recent reports described intense rapid warfarin potentiation. The interaction was fi
Publikováno v:
Seminars in thrombosis and hemostasis. 43(6)
Autor:
Einar Rosenqvist, Philipp Oster, Anne McNicholas, Steven Black, Johan Holst, Richard Arnold, Jane O'Hallahan, Lisbeth Meyer Næss, Michael V. Tatley, Ingeborg S. Aaberge, Yvonne Galloway
Publikováno v:
Human Vaccines & Immunotherapeutics. 9:1241-1253
The utility of wild-type outer membrane vesicle (wtOMV) vaccines against serogroup B (MenB) meningococcal disease has been explored since the 1970s. Public health interventions in Cuba, Norway and New Zealand have demonstrated that these protein-base
Autor:
Desireé L. Kunac, Michael V. Tatley
Publikováno v:
Drug Safety. 34:59-71
Background: Despite the traditional focus being adverse drug reactions (ADRs), pharmacovigilance centres have recently been identified as a potentially rich and important source of medication error data. Objective: To identify medication errors in th
Autor:
Ruth L. Savage, Michael V. Tatley
Publikováno v:
Drug Safety. 30:195-201
The HMG-CoA reductase inhibitors ('statins') have come into widespread use internationally. There has been a long history of their use in New Zealand and this use has increased in recent years. There has also been an increase in the number of reports